Financials
- Market Capitalization 498.93 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry 생명공학
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2836 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 8.18 USD | -7.05% | -7.78% | -25.36% | +9.07% | 508.46 M USD | ||
| 2846 | MNPR Monopar Therapeutics Inc. - Common Stock | 74.62 USD | -3.15% | -3.18% | -33.37% | +36.62% | 500.86 M USD | ||
| 2850 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.65 USD | -1.20% | +4.43% | -8.33% | -20.67% | 498.83 M USD | ||
| 2874 | ALT Altimmune, Inc. - Common Stock | 2.48 USD | -3.13% | -7.46% | -24.16% | -36.73% | 482.40 M USD |